We expect Vertex Pharmaceuticals Incorporated (VRTX) to surpass expectations when it reports first-quarter 2025 results on May 5, after market close. The Zacks Consensus Estimate for the to-be-reported quarter’s revenues is pegged at $2.82 billion, while the same for earnings is$4.22 per share. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar)Year to date, shares of Vertex have rallied 23.3% against the industry’s decline of 5.2%.Image Source: Zacks Investment ResearchFactors Shaping ...